Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1980-07-07
1982-02-09
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424 24, 424 26, 424 27, 424 28, A61K 3170, C07H 1906, C07H 1908, C07H 1910
Patent
active
043150004
ABSTRACT:
Hydroxy, amino and sulfhydryl derivatives of 1-.beta.-D-arabinofuranosyl-1H-imidazo[4,5-c]pyridine, their corresponding esters and non-toxic pharmaceutically acceptable salts are produced by arabinofuranosylation of the requisite heterocycles with 2,3,5-tri-O-benzyl-.alpha.-D-arabinofuranosyl halide and further reaction to obtain the desired compounds. These water soluble compounds are resistant to adenosine deaminase and exhibit antiviral activity.
REFERENCES:
patent: 3472838 (1969-10-01), Haressian
patent: 3501456 (1970-03-01), Shen
patent: 3651045 (1972-03-01), Haskell et al.
patent: 3703507 (1972-11-01), Haskell et al.
patent: 4048432 (1977-09-01), Baker
patent: 4055717 (1977-10-01), Baker
patent: 4056674 (1977-11-01), Robins et al.
patent: 4069382 (1978-01-01), Baker
Poonian et al., J. Med. Chem., 22, 958 (1979).
Cook et al., J. Am. Chem. Soc., 98, 1492 (1976).
Glandeman et al., J. Org. Chem., 28, 3004 (1963).
Hazel Blondel
Patton Walter
Warner-Lambert & Company
LandOfFree
.beta.-D-Arabinofuranosylimidazo(4,5-c)pyridine compounds and me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-D-Arabinofuranosylimidazo(4,5-c)pyridine compounds and me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-D-Arabinofuranosylimidazo(4,5-c)pyridine compounds and me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1260599